Clinical Trial Update: A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating larazotide acetate for treatment of celiac disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• larazotide acetate (larazotide acetate)

Snippet

Sponsor: 9 Meters Biopharma, Inc. | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED